期刊文献+

肝硬化失代偿期外周血细胞减少成因机制 被引量:6

Inducing peripheral blood cells for a decrease in decompensated cirrhosis
下载PDF
导出
摘要 肝硬化失代偿期并发的脾功能亢进和血细胞减少,互为因素,相互影响,是造成病情进展的重要原因.部分患者脾脏切除后,外周血细胞不仅无增加,反而出现进行性下降的表现,表明在肝硬化时外周血细胞减少,除了脾脏及病毒因素外也存有其他因素参与这一病程.各种免疫细胞因子变化、造血干细胞的状态都可能参与和调节肝硬化失代偿期外周血细胞减少这一过程,阐释肝硬化失代偿期外周血细胞减少成因机制对治疗意义重大,值得深入研究. Decompensated cirrhosis complicated with hypersplenism and hypocytosis are related and influence each other, with the latter being an important aggravating cause of the disease. Peripheral blood cells of some patients with cirrhosis after splenectomy not only do not increase, but actually decrease gradually. These results indicate that declining peripheral blood cells in patients with cirrhosis may be the result of factors in addition to the spleen and viral factors. Current research shows that various immune cytokine changes and hematopoietic stem cells states are likely to be involved and regulate the process of decreasing the number of peripheral blood cells in decompensated cirrhosis. It is suggested that inducing peripheral blood cells to cause a decrease in decompensated cirrhosis is worthy of more indepth study as a potential therapy.
作者 党双锁
出处 《世界华人消化杂志》 CAS 北大核心 2007年第27期2861-2864,共4页 World Chinese Journal of Digestology
基金 国家自然科学基金项目 No 30670961~~
关键词 肝硬化 脾功能亢进 造血干细胞 免疫反应 Hepatic cirrhosis Hypersplenism He-mopoietic stem cells Immune reaction
  • 相关文献

参考文献12

  • 1Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, Alison MR. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroen terology 2004; 126:955-963. 被引量:1
  • 2张伟辉,赵松,付英梅,刘连新,王晓春,武林枫.肝硬化门静脉高压症患者脾切除术后血细胞数减少的病因分析[J].中华医学杂志,2005,85(18):1285-1286. 被引量:9
  • 3柏树令,赵丹.CD34抗原的生物学特性及其临床应用[J].解剖科学进展,2005,11(1):54-56. 被引量:40
  • 4Alison MR, Golding MH, Sarraf CE. Pluripotential liver stem cells: facultative stem cells located in the biliary tree. Cell Prolif1996; 29:373-402. 被引量:1
  • 5Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001; 120:534-544. 被引量:1
  • 6冯凯,马宽生.继发性脾功能亢进症的治疗现状及展望[J].国外医学(外科学分册),2005,32(3):183-187. 被引量:11
  • 7Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378:88-91. 被引量:1
  • 8Lin SD, Kawakami T, Ushio A, Sato A, Sato S, Iwai M, Endo R, Takikawa Y, Suzuki K. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure. J Gastroenterol Hepatol 2006; 21:374-380. 被引量:1
  • 9Manigold T, Bocker U, Chen J, Gundt J, Traber P, Singer MV, Rossol S. Hepatitis B core antigen is a potent inductor of intefleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection. J Med Virol 2003; 71:31-40. 被引量:1
  • 10Brugger W, Mocklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 1993; 81:2579-2584. 被引量:1

二级参考文献14

  • 1邹萍,向建平,陈智超,李崇渔.急性髓系白血病细胞CD_(34)抗原表达的研究Ⅰ表达特点和临床意义[J].中华血液学杂志,1994,15(7):339-341. 被引量:28
  • 2操州虹,刘秀芳,王辨明.不同病期慢性粒细胞白血病CD_(34)阳性细胞的临床意义[J].中华血液学杂志,1996,17(1):10-12. 被引量:3
  • 3方炳木,国外医学输血及血液学分册,1993年,19卷,90页 被引量:1
  • 4Osawa M,Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34 - low/negative hematopietic stem cell [J]. Science, 1996,273 (5272): 242 - 245. 被引量:1
  • 5Huss R. CD34 - stem cells as the earliest precursors of hempatopoietic progeny[J]. Exp Hematol,1998,26(11) :1022 - 1023. 被引量:1
  • 6Halens S, Kohn DB. Gene therapy using hematopoietic stem cells:sisyphus approaches the cerst[J]. Human Gene Therapy,2000,11(9) :1259 - 1267. 被引量:1
  • 7Cornelissen JJ, Vander Hdt B, Petersen EJ, et al. A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies [J]. Exp Hematol,2003,31 (10) :855 -864. 被引量:1
  • 8Vogle W, Behringer D, Scheding S, et al. Ex vivo expansion of CD34 + peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells[J]. Blood,1996,88(7) :2707 -2713. 被引量:1
  • 9Brugger W, Heimfeld S, Berenson RJ, et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo[J]. N Eng J Med, 1995,333 (5) :283 -287. 被引量:1
  • 10Harraz M, Jiao C, Hanlon HD, et al. CD34- blood-derived human endothelial cell progenitors[J]. Stem Gells,2001,19(4) :304-312. 被引量:1

共引文献85

同被引文献71

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部